Adwaya Pharco International Signs Technology Agreement with Shilpa Pharma Lifesciences at CPHI Milan 2026

13 October 2026Corporate

Adwaya Pharco International, Pharco’s arm in Saudi Arabia, signed an S&L agreement with Shilpa Pharma Lifesciences during CPHI Milan 2026. The agreement provides access to an innovative technology intended to strengthen the company’s capabilities and support its continued growth in the Saudi market.

The collaboration forms part of Addwaya Pharco International’s efforts to introduce new technologies and solutions to Saudi Arabia. Through this agreement, the company aims to expand its capabilities and create further opportunities for its business in the Kingdom.

The signing marks a new step in the company’s development, supporting Pharco’s commitment to building partnerships that advance its presence in the Saudi pharmaceutical market.

— Pharco press release.

Back to News & Events

CorporatePharco Group

Newsroom

More stories

View all news

Pharco Pharmaceuticals and Alameda Healthcare Group Sign Strategic Memorandum of Understanding to Strengthen Integrated Healthcare in Egypt

Corporate

15 October 2026

Pharco Pharmaceuticals and Alameda Healthcare Group Sign Strategic Memorandum of Understanding to Strengthen Integrated Healthcare in Egypt

Pharco Pharmaceuticals, a leading pharmaceutical company, and Alameda Healthcare Group, a prominent healthcare provider, have signed a strategic Memorandum of Understanding (MoU) to strengthen cooperation between pharmaceutical manufacturing and healthcare delivery. The agreement aims to improve care for patients in Egypt and advance collaboration in scientific research and medical education.

Read story

Pharco and Baheya Hospitals Sign Memorandum of Understanding to Support Cancer Care

Corporate

05 October 2026

Pharco and Baheya Hospitals Sign Memorandum of Understanding to Support Cancer Care

Pharco Pharmaceuticals signed a Memorandum of Understanding with Baheya Hospitals to strengthen cooperation in oncology care and support the development of healthcare services. The signing took place in the presence of Dr. Sherine Helmy, Chairman and CEO of Pharco Pharmaceuticals.

Read story

Pharco Opens New Eye Drops Line, Launches "Vision for All" Initiative

Manufacturing

28 July 2026

Pharco Opens New Eye Drops Line, Launches "Vision for All" Initiative

Pharco has switched on a new eye drops production line at its Amreya City site in Alexandria. Alongside it, the company is launching a broader push to get more people across Egypt and the region screened for eye disease before it does lasting damage.

Read story

Press & media inquiries

For interview requests, image assets, or fact-checks, please contact our communications team directly.

Contact Press Office